retatrutide micro dosing Dosage: Titration Schedule Microdosing Retatrutide 101: Expert Overview

Looking Ahead One of the big unanswered questions with GLP-1 therapy is what happens when patients stop taking the medication

This is where confusion often creeps in, especially for people new to tirzepatide dosing in units

David Amron

Once these biomarkers are stable and symptoms are minimal, its usually safer and more effective to start a GLP-1

For Lilly internally, retatrutide moves from a hopeful pipeline asset to a pillar of the company's late-decade franchise alongside tirzepatide, which still dominates the dual-agonist segment, and oral orforglipron, which has its own ATTAIN-1 data showing 12.4% loss in non-diabetic adults

That reality explains why regulators, legislators, and patent holders have focused on this category